Clinical Trials

We are currently investigating multiple indications in the axicabtagene ciloleucel and the KTE-C19 development program as well as for our TCR pipeline and second generation technology. Our areas of research include a variety of blood cancers and solid tumors.

View our clinical trials on ClinicalTrials.gov